Download Free Sample Report

Global Zebrafish Disease Models market was valued at 24.2 million in 2024 and is projected to reach USD 34.7 million by 2032, at a CAGR of 5.4% during the forecast period.

The zebrafish is an important and widely used vertebrate model organism in scientific research, for example in drug development, in particular pre-clinical development. It is also notable for its regenerative abilities, and has been modified by researchers to produce many transgenic strains.
The U.S. market is estimated at D million in 2024, while China is to reach D million.
Epilepsy Model segment will reach D million by 2032, with a % CAGR in next six years.

The global key players of Zebrafish Disease Models include Shanghai Model Organisms Center, Inc., ZeClinics, InVivo Biosystems, Biobide, Pentagrit, Evotec, Aurigene Pharmaceutical Services, Ikan Biotech, Bioreperia, Hangzhou Hunter Biotechnology Co., Ltd., etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Zebrafish Disease Models companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks

This report aims to provide a comprehensive presentation of the global market for Zebrafish Disease Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zebrafish Disease Models.

This report contains market size and forecasts of Zebrafish Disease Models in global, including the following market information:

• Global Zebrafish Disease Models market revenue, 2020-2025, 2026-2032, (D millions)
• Global top five Zebrafish Disease Models companies in 2024 (%)

Total Market by Segment:
Global Zebrafish Disease Models market, by Type, 2020-2025, 2026-2032 (D millions)
Global Zebrafish Disease Models market segment percentages, by Type, 2024 (%)

• Epilepsy Model
• Parkinson Disease Model
• Retinal Degeneration Model
• Metabolic Disorders and Obesity Model

Global Zebrafish Disease Models market, by Application, 2020-2025, 2026-2032 (D millions)
Global Zebrafish Disease Models market segment percentages, by Application, 2024 (%)

• Pharmaceutical
• Biotechnology

Global Zebrafish Disease Models market, by region and country, 2020-2025, 2026-2032 (D millions)
Global Zebrafish Disease Models market segment percentages, by region and country, 2024 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA) 

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Zebrafish Disease Models revenues in global market, 2020-2025 (estimated), (D millions)
• Key companies Zebrafish Disease Models revenues share in global market, 2024 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Shanghai Model Organisms Center, Inc.
• ZeClinics
• InVivo Biosystems
• Biobide
• Pentagrit
• Evotec
• Aurigene Pharmaceutical Services
• Ikan Biotech
• Bioreperia
• Hangzhou Hunter Biotechnology Co., Ltd.
• YSY BIOTECH
• Eze-Rinka
• INVENesis
• FEIFAN TEST
• Charles River Laboratories

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Zebrafish Disease Models, market overview.
• Chapter 2: Global Zebrafish Disease Models market size in revenue.
• Chapter 3: Detailed analysis of Zebrafish Disease Models company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Zebrafish Disease Models in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: The main points and conclusions of the report.